Revance Therapeutics reported $1.13B in Market Capitalization this June of 2022, considering the latest stock price and the number of outstanding shares.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Abbvie ABBV:US $ 286.33B 46.96B
Aerie Pharmaceuticals AERI:US $ 0.44B 0.11B
ALKERMES ALKS:US 4.26B 0.49B
Antares Pharma ATRS:US $ 0.7B 0.09B
Bristol Myers Squibb BMY:US $ 155.49B 17.09B
Cara Therapeutics CARA:US $ 0.65B 0B
Coherus Biosciences CHRS:US $ 1B 0.23B
Eli Lilly And LLY:US $ 272.72B 8.49B
Endo International Ordinary Shares ENDP:US 0.54B 0.34B
Horizon Pharma HZNP:US 24.14B 0.3B
JAZZ PHA JAZZ:US 9.61B 1.78B
Johnson & Johnson JNJ:US $ 466.05B 15.69B
Merk MRK:US $ 207.45B 13.86B
Neurocrine Biosciences NBIX:US $ 8.95B 0.87B
Pacira Pharmaceuticals PCRX:US $ 3.42B 0.74B
Procter & Gamble PG:US $ 366.61B 25.5B
Revance Therapeutics RVNC:US $ 1.4B 0.23B
Supernus Pharmaceuticals SUPN:US $ 1.72B 0.17B
Teva Pharmaceutical Industries TEVA:US 10.29B 0.72B